|
RANBP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.69419963905682E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.89730003614153E-09 |
| Normal-vs-Stage2 |
1.023610E-02 |
| Normal-vs-Stage3 |
3.92530000000724E-05 |
| Normal-vs-Stage4 |
1.643720E-02 |
| Stage1-vs-Stage2 |
4.218000E-01 |
| Stage1-vs-Stage3 |
7.102600E-01 |
| Stage1-vs-Stage4 |
9.598200E-01 |
| Stage2-vs-Stage3 |
2.625000E-01 |
| Stage2-vs-Stage4 |
5.024000E-01 |
| Stage3-vs-Stage4 |
8.396000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51280116106523E-11 |
| Normal-vs-AfricanAmerican |
4.715500E-03 |
| Normal-vs-Asian |
1.151380E-01 |
| Caucasian-vs-AfricanAmerican |
2.289900E-02 |
| Caucasian-vs-Asian |
7.434400E-01 |
| AfricanAmerican-vs-Asian |
6.689800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08170147786291E-11 |
| Normal-vs-Female |
5.619600E-03 |
| Male-vs-Female |
1.325910E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.024520E-04 |
| Normal-vs-Extreme_Weight |
3.16600079486307E-11 |
| Normal-vs-Obese |
1.78025999999498E-05 |
| Normal-vs-Extreme_Obese |
1.459350E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.463400E-01 |
| Normal_Weight-vs-Obese |
5.354200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.111000E-01 |
| Extreme_Weight-vs-Obese |
5.384200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.036200E-01 |
| Obese-vs-Extreme_Obese |
9.427200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.245800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.04939999981902E-07 |
| Normal-vs-Age(61-80Yrs) |
4.85219975310258E-10 |
| Normal-vs-Age(81-100Yrs) |
3.211200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.908200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.211400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.458300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.004620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.907600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.509800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.89249998899999E-09 |
| Normal-VS-Type2 PRCC |
1.07860000042592E-07 |
| Normal-VS-KIRP CIMP |
1.444810E-01 |
| Normal-VS-Unclassified PRCC |
3.229200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.774400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.238000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.321000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.152600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.080200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.508400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29550004057677E-09 |
| Normal-vs-N1 |
4.123700E-03 |
| Normal-vs-N2 |
4.23699999996252E-06 |
| N0-vs-N1 |
2.923600E-02 |
| N0-vs-N2 |
4.025600E-02 |
| N1-vs-N2 |
4.770400E-02 |
|
|
